Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Technetium-99
48%
Positron Emission Tomography
47%
Succimer
37%
Fluorodeoxyglucose F 18
37%
Positron Emission Tomography - Magnetic Resonance Imaging
35%
Polyethylene Terephthalate
34%
Scintigraphy
32%
Computer Assisted Tomography
29%
Bone Scintigraphy
28%
Magnetic Resonance Imaging
27%
Kidney Function
27%
Neoplasm
26%
Radioisotope
25%
Pelvis
24%
Single-Photon Emission Computed Tomography
24%
Prostate Cancer
23%
Prostate Specific Membrane Antigen
20%
Diseases
20%
Fluorodeoxyglucose
19%
Fluorine-18
18%
Standardized Uptake Value
17%
Radioisotope Renography
15%
Kidney Tubule Absorption
14%
Erythrocyte
13%
Prospective Study
12%
Prostatectomy
12%
Overall Survival
11%
Contralateral
11%
Chemoradiotherapy
11%
Stomach Emptying
11%
Biological Marker
9%
Stress Fracture
9%
Colorectal Carcinoma
9%
Choline
9%
Gallium 68
9%
Lower Limb
9%
Tumor
9%
Infection
9%
Rectum Cancer
8%
Injection
8%
Kidney Tumour
7%
Retrospective Study
7%
Metastatic Carcinoma
7%
Carbon 11
7%
Liver Metastasis
7%
Urine Flow Rate
7%
Retrospective Cohort Study
7%
Malignant Neoplasm
6%
Nephropathy
6%
Keyphrases
Positron Emission Tomography/computed Tomography (PET/CT)
88%
PET-MRI
49%
Technetium-99m
39%
Kidney
36%
Dimercaptosuccinic Acid
29%
Scintigraphy
24%
18F-FDG PET-CT
22%
SUVmax
20%
Single-photon Emission Computed Tomography (SPECT)
19%
18F-fluorodeoxyglucose (18F-FDG)
18%
Quantitative SPECT
18%
FDG Uptake
17%
Liver
16%
Acid Uptake
15%
Cardiac Magnetic Resonance Imaging (cMRI)
15%
Bone Scintigraphy
14%
Renal Function
14%
Pelvis
13%
Renal Scintigraphy
12%
Kidney Uptake
12%
Standardized Uptake Value
10%
Prostate-specific Membrane Antigen Positron Emission Tomography
9%
Prostate-specific Membrane Antigen
9%
Radionuclides
9%
18F-FDG Positron Emission Tomography
9%
Hemangioma
9%
Image Features
9%
Early Prediction
9%
Standard of Care
9%
Blood Pool
9%
Abdomen
8%
Gastric Emptying Scintigraphy
8%
Colloids
8%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
8%
Spleen
7%
Labeled Red Blood Cells
7%
Oncologic
7%
Computed Tomography
7%
Histological Response
7%
After Surgery
7%
Rectal Cancer
7%
Liver Metastasis
7%
Contrast-enhanced Computed Tomography
7%
Tumor Volume
6%
Metabolic Tumor Volume
6%
Metabolic
6%
Pathological Complete Response
6%
Diagnostic Performance
6%
FDG PET-CT
6%
Crohn's Disease
6%